全文获取类型
收费全文 | 2346241篇 |
免费 | 176170篇 |
国内免费 | 3355篇 |
专业分类
耳鼻咽喉 | 32277篇 |
儿科学 | 76206篇 |
妇产科学 | 63149篇 |
基础医学 | 347243篇 |
口腔科学 | 63876篇 |
临床医学 | 211783篇 |
内科学 | 455142篇 |
皮肤病学 | 52042篇 |
神经病学 | 185512篇 |
特种医学 | 88387篇 |
外国民族医学 | 489篇 |
外科学 | 354392篇 |
综合类 | 47521篇 |
现状与发展 | 12篇 |
一般理论 | 874篇 |
预防医学 | 183130篇 |
眼科学 | 54569篇 |
药学 | 175514篇 |
9篇 | |
中国医学 | 4432篇 |
肿瘤学 | 129207篇 |
出版年
2019年 | 20117篇 |
2018年 | 27652篇 |
2017年 | 20774篇 |
2016年 | 23196篇 |
2015年 | 26132篇 |
2014年 | 36754篇 |
2013年 | 54844篇 |
2012年 | 75900篇 |
2011年 | 80644篇 |
2010年 | 47781篇 |
2009年 | 45143篇 |
2008年 | 75566篇 |
2007年 | 80386篇 |
2006年 | 81087篇 |
2005年 | 78552篇 |
2004年 | 75091篇 |
2003年 | 72158篇 |
2002年 | 69690篇 |
2001年 | 108769篇 |
2000年 | 111326篇 |
1999年 | 93057篇 |
1998年 | 25436篇 |
1997年 | 22043篇 |
1996年 | 22417篇 |
1995年 | 22638篇 |
1994年 | 20843篇 |
1993年 | 19664篇 |
1992年 | 71992篇 |
1991年 | 70170篇 |
1990年 | 68465篇 |
1989年 | 65714篇 |
1988年 | 60339篇 |
1987年 | 59172篇 |
1986年 | 55289篇 |
1985年 | 53083篇 |
1984年 | 39316篇 |
1983年 | 33362篇 |
1982年 | 19815篇 |
1981年 | 17820篇 |
1979年 | 35848篇 |
1978年 | 25646篇 |
1977年 | 21185篇 |
1976年 | 20315篇 |
1975年 | 21812篇 |
1974年 | 26163篇 |
1973年 | 24826篇 |
1972年 | 23239篇 |
1971年 | 22065篇 |
1970年 | 20273篇 |
1969年 | 19337篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
Syed S. Razi Joy A. Stephens-McDonnough Safi Haq Michael Fabbro Aliercy Nunez Sanchez Richard H. Epstein Nestor R. Villamizar Dao M. Nguyen 《The Journal of thoracic and cardiovascular surgery》2021,161(5):1689-1701
ObjectiveTo evaluate differences in postoperative pain control and opioids requirement in thoracic surgical patients following implementation of an Enhanced Recovery after Thoracic Surgery protocol with a comprehensive postoperative pain management strategy.Material and MethodsA retrospective analysis of a prospectively maintained database of patients undergoing pulmonary resections by robotic thoracoscopy or thoracotomy from January 1, 2017, to January 31, 2019, was conducted. Multimodal pain management strategy (opioid-sparing analgesics, infiltration of liposomal bupivacaine to intercostal spaces and surgical sites, and elimination of thoracic epidural analgesia use in thoracotomy patients) was implemented as part of Enhanced Recovery after Thoracic Surgery on February 1, 2018. Outcome metrics including patient-reported pain levels, in-hospital and postdischarge opioids use, postoperative complications, and length of stay were compared before and after protocol implementation.ResultsIn total, 310 robotic thoracoscopy and 62 thoracotomy patients met the inclusion criteria. This pain management strategy was associated with significant reduction of postoperative pain in both groups with an overall reduction of postoperative opioids requirement. Median in-hospital opioids use (morphine milligram equivalent per day) was reduced from 30 to 18.36 (P = .009) for the robotic thoracoscopy group and slightly increased from 15.48 to 21.0 (P = .27) in the thoracotomy group. More importantly, median postdischarge opioids prescribed (total morphine milligram equivalent) was significantly reduced from 480.0 to 150.0 (P < .001) and 887.5 to 150.0 (P < .001) for the thoracoscopy and thoracotomy groups, respectively. Similar short-term perioperative outcomes were observed in both groups before and following protocol implementation.ConclusionsImplementation of Enhanced Recovery after Thoracic Surgery allows safe elimination of epidural use, better pain control, and less postoperative opioids use, especially a drastic reduction of postdischarge opioid need, without adversely affecting outcomes. 相似文献
102.
103.
Vicki A. Morrison 《Journal of Geriatric Oncology》2021,12(2):320-325
A major evolution in the treatment of patients with diffuse large B-cell lymphoma (DLBCL) occurred almost two decades ago, with clinical trials demonstrating that the addition of rituximab (R) to cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP), which had been the “gold standard” of therapy since 1976, significantly improved outcome, including response rate and disease-free survival, of these patients. Since the adoption of R-CHOP, subsequent clinical trials have attempted to improve upon outcomes achieved with R-CHOP, with a variety of approaches examined. These have included dose intensification, which may be applicable in younger patients, but not in the many older or frailer patients with a disease with median age at diagnosis in the 60's. Newer anti-CD20 monoclonal antibodies have been substituted for rituximab in frontline regimens. A series of new agents, with unique mechanisms of action, have been added to the R-CHOP backbone. Rituximab-based, non-anthracycline regimens have been studied for older, more frail patients. The utility of maintenance therapy in responding patients has been re-examined, despite the lack of benefit found in the US Intergroup trial. Advances in molecular and genetic aspects of DLBCL have emerged since the seminal R-CHOP trials, demonstrating the DLBCL is not a single entity, but instead a spectrum of multiple disease subtypes. Attempts have been made to identify those patients at baseline who have poorer outcomes with standard approaches, utilizing laboratory and imaging findings. Moving forward, different risk-adapted treatment approaches will be studied to in an effort to improve overall outcome beyond R-CHOP. 相似文献
104.
R. García-Ramos D. Santos-García A. Alonso-Cánovas M. Álvarez-Sauco B. Ares A. Ávila N. Caballol F. Carrillo F. Escamilla Sevilla E. Freire J.C. Gómez Esteban I. Legarda L. López Manzanares E. López Valdés I. Martínez-Torres M. Mata I. Pareés B. Pascual-Sedano J.C. Martínez Castrillo 《Neurología (Barcelona, Spain)》2021,36(2):149-158
IntroductionThe main challenge of Parkinson's disease in women of childbearing age is managing symptoms and drugs during pregnancy and breastfeeding. The increase in the age at which women are having children makes it likely that these pregnancies will become more common in future.ObjectivesThis study aims to define the clinical characteristics of women of childbearing age with Parkinson's disease and the factors affecting their lives, and to establish a series of guidelines for managing pregnancy in these patients.ResultsThis consensus document was developed through an exhaustive literature search and a discussion of the available evidence by a group of movement disorder experts from the Spanish Society of Neurology.ConclusionsParkinson's disease affects all aspects of sexual and reproductive health in women of childbearing age. Pregnancy should be well planned to minimise teratogenic risk. A multidisciplinary approach should be adopted in the management of these patients in order to take all relevant considerations into account. 相似文献
105.
106.
107.
Andreas Glenthj Lasse H. Jakobsen Henrik Sengelv Syed A. Ahmad Kristian Qvist Annika Rewes Christian B. Poulsen Ulrik M. Overgaard Ingolf Mlle Marianne T. Severinsen Casper N. Strandholdt Jack Maibom Annette R. Kodahl Jesper Ryg Pernille Ravn Isik S. Johansen Sren N. Hels Sren Jensen‐Fangel Jacek Kisielewicz Lothar Wiese Marie Helleberg Ole Kirk Michael R. Clausen Henrik Frederiksen 《European journal of haematology》2021,106(1):72-81
108.
109.
Sarah J. Schrauben Haochang Shou Xiaoming Zhang Amanda Hyre Anderson Joseph V. Bonventre Jing Chen Steven Coca Susan L. Furth Jason H. Greenberg Orlando M. Gutierrez Joachim H. Ix James P. Lash Chirag R. Parikh Casey M. Rebholz Venkata Sabbisetti Mark J. Sarnak Michael G. Shlipak Sushrut S. Waikar Paul L. Kimmel Ramachandran S. Vasan Harold I. Feldman Jeffrey R. Schelling 《Journal of the American Society of Nephrology : JASN》2021,32(1):115
110.